Hostname: page-component-54dcc4c588-sdd8f Total loading time: 0 Render date: 2025-10-12T20:06:50.922Z Has data issue: false hasContentIssue false

Impact of Periprocedural Hemoglobin Level on the Outcomes of Endovascular Thrombectomy in Acute Ischemic Stroke Patients

Published online by Cambridge University Press:  02 April 2025

Zaid Najdawi
Affiliation:
Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA
Mohamed Elfil
Affiliation:
Department of Neurology, University of Miami/Jackson Health System, Miami, FL, USA
Abdallah Abbas
Affiliation:
Faculty of Medicine, Al-Azhar University, Damietta, Egypt
Lilian Maria Godeiro Coelho
Affiliation:
Department of Neurology, University of Miami/Jackson Health System, Miami, FL, USA
Ahmed Samir
Affiliation:
Faculty of Medicine, Al-Azhar University, Damietta, Egypt
Sharon Peng
Affiliation:
Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA
Mohammad Aladawi
Affiliation:
Department of Neurology, University of Alabama, Birmingham, AL, USA
Hazem S. Ghaith
Affiliation:
Faculty of Medicine, Al-Azhar University, Cairo, Egypt
Mohammad El-Ghanem
Affiliation:
Department of Clinical Sciences, University of Houston. HCA Houston Healthcare/ HCA Northwest Medical Center, Houston, TX, USA
Chirag D. Gandhi
Affiliation:
Department of Neurosurgery, Westchester Medical Center, Valhalla, NY, USA
Fawaz Al-Mufti*
Affiliation:
Department of Neurosurgery, Westchester Medical Center, Valhalla, NY, USA
*
Corresponding author: Fawaz Al-Mufti; Email: Fawaz.Al-Mufti@wmchealth.org

Abstract

Background:

Endovascular thrombectomy (EVT) is the gold standard treatment for acute ischemic stroke (AIS) patients with large vessel occlusion (LVO). Multiple factors can influence EVT outcomes, including procedural and patient-related variables. This meta-analysis investigated the impact of periprocedural hemoglobin (Hb) levels on EVT outcomes.

Methods:

We performed a comprehensive literature search across PubMed, Scopus, Web of Science and Cochrane CENTRAL. We analyzed the mean difference (MD) in Hb levels between good (modified Rankin Scale [mRS] 0–2) and poor (mRS 3–6) prognosis groups. We calculated pooled odds ratios (OR) for Hb levels as a predictor of prognosis and compared mortality and symptomatic intracranial hemorrhage (sICH) across different Hb levels.

Results:

The analysis included 921 patients from four studies. Patients in the good prognosis group had significantly higher Hb levels (MD: 0.48 g/dL, 95% CI: [0.2, 0.75], P = 0.0007). Each 1 g/dL increase in Hb was associated with a 22% increase in the odds of achieving a good three-month prognosis (OR: 1.22, 95% CI: [1.13, 1.33], P < 0.00001). Patients with Hb levels ≤13 g/dL in males and ≤12 g/dL in females were 1.69 times more likely to experience mortality (OR: 1.69, 95% CI: [1.1, 2.59], P = 0.02). No significant difference was observed in sICH occurrence between anemic and non-anemic patients.

Conclusion:

Higher Hb levels may be associated with improved prognosis, and lower Hb levels might increase mortality risk in AIS-LVO patients undergoing EVT. Further research is needed to validate these findings.

Résumé

RÉSUMÉ

Impact des taux d’hémoglobine péri-procéduraux sur les résultats de la thrombectomie endovasculaire chez des patients victimes d’un AVC ischémique aigu.

Contexte :

La thrombectomie endovasculaire (TEV) est le traitement de référence pour les patients victimes d’un AVC ischémique aigu entraînant une occlusion des gros vaisseaux sanguins (OGVS). De multiples facteurs peuvent influencer les résultats de la thrombectomie endovasculaire, y compris des variables liées à la procédure elle-même et aux patients. Cette méta-analyse a donc étudié l’impact des taux d’hémoglobine (Hb) péri-procéduraux sur les résultats de la TEV.

Méthodes :

Nous avons effectué une recherche documentaire exhaustive dans PubMed, Scopus, Web of Science et CENTRAL. Nous avons ensuite analysé la différence moyenne (DM) des taux d’Hb entre les groupes offrant un bon pronostic (échelle de Rankin modifiée [ERM] 0-2) et un mauvais pronostic (ERM 3-6). Nous avons calculé les rapports de cote (RC) regroupés pour les taux d’Hb en tant que prédicteurs du pronostic et comparé les taux de mortalité et la présence d’hémorragie intracrânienne symptomatique (HICS) en fonction des différents niveaux d’Hb.

Résultats :

Notre analyse a porté sur 921 patients issus de quatre études. Les patients des groupes offrant un bon pronostic avaient des taux d’Hb significativement plus élevés (DM : 0,48 g/dL ; IC 95 % : [0,2-0,75], p = 0,0007). Chaque augmentation de 1 g/dL du taux d’Hb était associée à une augmentation de 22 % de chance d’obtenir un bon pronostic au bout de trois mois (RC : 1,22 ; IC 95 % : [1,13-1,33], p < 0,00001). Les patients ayant un taux d’Hb ≤ 13 g/dL chez les hommes et ≤ 12 g/dL chez les femmes avaient 1,69 fois plus de chance de décéder (RC : 1,69 ; IC 95 % : [1,1-2,59], p = 0,02). Finalement, aucune différence notable entre les patients anémiques et non anémiques n’a été observée en ce qui regarde la présence d’une HICS.

Conclusion :

Des taux d’Hb plus élevés peuvent être associés à un meilleur pronostic alors que des taux d’Hb plus bas peuvent augmenter le risque de mortalité chez des patients victimes d’un AVC ischémique aigu entraînant une OGVS et devant subir une TEV. Chose certaine, des recherches supplémentaires sont nécessaires pour valider de tels résultats.

Information

Type
Original Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Powers, WJ, Rabinstein, AA, Ackerson, T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344e418.CrossRefGoogle Scholar
Ceulemans, A, Pinckaers, FME, Postma, AA, van Zwam, WH, van Oostenbrugge, RJ. Association between anemia and clinical outcome in acute ischemic stroke patients treated with endovascular treatment. J Stroke. 2024;26(1):8794.CrossRefGoogle ScholarPubMed
Nisar, T, Lebioda, K, Shaulov, S, et al. Interplay between anemia parameters and collateral status in patients who undergo mechanical thrombectomy. J Clin Neurosci. 2022;104:3441.CrossRefGoogle ScholarPubMed
Merlino, G, Smeralda, C, Sponza, M, et al. Dynamic hyperglycemic patterns predict adverse outcomes in patients with acute ischemic stroke undergoing mechanical thrombectomy. J Clin Med. 2020;9(6):1932. doi: 10.3390/jcm9061932.CrossRefGoogle ScholarPubMed
Rhiner, N, Thut, MZ, Thurner, P, et al. Impact of age on mechanical thrombectomy and clinical outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2023;32(9):107248.10.1016/j.jstrokecerebrovasdis.2023.107248CrossRefGoogle ScholarPubMed
Salwi, S, Cutting, S, Salgado, AD, et al. Mechanical thrombectomy in patients with ischemic stroke with prestroke disability. Stroke. 2020;51(5):15391545.10.1161/STROKEAHA.119.028246CrossRefGoogle ScholarPubMed
Chen, HF, Ho, TF, Kuo, YH, Chien, JH. Association between anemia severity and ischemic stroke incidence: a retrospective cohort study. Int J Environ Res Public Health. 2023;20(5):3849.CrossRefGoogle ScholarPubMed
Ioannou, GN, Dominitz, JA, Weiss, NS, Heagerty, PJ, Kowdley, KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology. 2004;126(5):12931301.10.1053/j.gastro.2004.01.020CrossRefGoogle ScholarPubMed
Chen, H, Ahmad, G, Phipps, MS, et al. Peri-procedural decrease in hemoglobin following mechanical thrombectomy for ischemic stroke. Interv Neuroradiol. 2023. doi: 10.1177/15910199231205627.CrossRefGoogle Scholar
Akpinar, CK, Gurkas, E, Aytac, E. Moderate to severe anemia is associated with poor functional outcome in acute stroke patients treated with mechanical thrombectomy. Interv Neurol. 2018;7(1-2):1218.10.1159/000480642CrossRefGoogle ScholarPubMed
Pienimaki, JP, Protto, S, Hakomaki, E, Jolma, P, Sillanpaa, N. Anemia predicts poor clinical outcome in mechanical thrombectomy patients with fair or good collateral circulation. Cerebrovasc Dis Extra. 2020;10(3):139147.10.1159/000510228CrossRefGoogle ScholarPubMed
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefGoogle ScholarPubMed
Higgins, J, Thomas, J, Chandler, J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; 2022. updated February 2022.Google Scholar
Ouzzani, M, Hammady, H, Fedorowicz, Z, Elmagarmid, A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.10.1186/s13643-016-0384-4CrossRefGoogle ScholarPubMed
Wells, GA, Wells, G, Shea, B, Shea, B, O’Connell, D, Peterson, J, et al. editors. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses2014. 2014.Google Scholar
Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629634.10.1136/bmj.315.7109.629CrossRefGoogle ScholarPubMed
Feng, X, Zhang, Y, Li, Q, Wang, B, Shen, J. Hemoglobin to red cell distribution width ratio as a prognostic marker for ischemic stroke after mechanical thrombectomy. Front Aging Neurosci. 2023;15:1259668.10.3389/fnagi.2023.1259668CrossRefGoogle ScholarPubMed
Inui, R, Koge, J, Tanaka, K, et al. Detrimental effect of anemia after mechanical thrombectomy on functional outcome in patients with ischemic stroke. Front Neurol. 2023;14:1299891.10.3389/fneur.2023.1299891CrossRefGoogle ScholarPubMed
Lin, MT, Wu, HW, Chen, HY, Tsai, HT, Wu, CH. Association of clinical factors to functional outcomes in patients with stroke with large-vessel occlusion after endovascular thrombectomy. J Formos Med Assoc. 2023;122(4):344350.CrossRefGoogle ScholarPubMed
Nisar, T, Shapouran, S, Abu-Hadid, O, et al. Association of anemia with functional outcomes in patients with mechanical thrombectomy. Clin Neurol Neurosurg. 2021;211:107028.CrossRefGoogle ScholarPubMed
Wrona, P, Wrobel, D, Popadynets, V, et al. Predictors of good functional outcome in ischaemic stroke patients without delayed neurological improvement after mechanical thrombectomy. Neurol Neurochir Pol. 2024;58(2):185192.10.5603/pjnns.98219CrossRefGoogle ScholarPubMed
Kellert, L, Martin, E, Sykora, M, et al. Cerebral oxygen transport failure?: decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke: relevAnt impact of hemoGlobin, hematocrit and transfusion (STRAIGHT)--an observational study. Stroke. 2011;42(10):28322837.10.1161/STROKEAHA.110.606665CrossRefGoogle ScholarPubMed
Milionis, H, Papavasileiou, V, Eskandari, A, D’Ambrogio-Remillard, S, Ntaios, G, Michel, P. Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke. Int J Stroke. 2015;10(2):224230.CrossRefGoogle Scholar
Li, Z, Zhou, T, Li, Y, Chen, P, Chen, L. Anemia increases the mortality risk in patients with stroke: a meta-analysis of cohort studies. Sci Rep. 2016;6:26636.CrossRefGoogle ScholarPubMed
Gao, H, Peng, H, Yang, H, Li, Q, Xiang, X. Neurointerventional infusion of hemoglobin oxygen carrier prevents brain damage from acute cerebral ischemia in rats. Front Surg. 2023;10:1050935.10.3389/fsurg.2023.1050935CrossRefGoogle ScholarPubMed
Gekka, M, Abumiya, T, Komatsu, T, et al. Novel hemoglobin-based oxygen carrier bound with albumin shows neuroprotection with possible antioxidant effects. Stroke. 2018;49(8):19601968.CrossRefGoogle ScholarPubMed
Pensato, U, Bosshart, S, Stebner, A, et al. Effect of hemoglobin and blood glucose levels on CT perfusion ischemic core estimation: a post hoc analysis of the ESCAPE-NA1 trial. Neurology. 2024;103(10):e209939.10.1212/WNL.0000000000209939CrossRefGoogle Scholar
Agarwal, N, Prchal, JT. Anemia of chronic disease (anemia of inflammation). Acta Haematol. 2009;122(2-3):103108.10.1159/000243794CrossRefGoogle ScholarPubMed
Means, RT Jr. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells. 1995;13(1):3237.CrossRefGoogle ScholarPubMed
Castellanos, M, Castillo, J, Garcia, MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke. 2002;33(4):982987.10.1161/hs0402.105339CrossRefGoogle ScholarPubMed
Pawluk, H, Grzesk, G, Kolodziejska, R, et al. Effect of IL-6 and hsCRP serum levels on functional prognosis in stroke patients undergoing IV-thrombolysis: retrospective analysis. Clin Interv Aging. 2020;15:1295–303.10.2147/CIA.S258381CrossRefGoogle ScholarPubMed
Hultcrantz, M, Modlitba, A, Vasan, SK, et al. Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors. Thromb Res. 2020;186:8692.CrossRefGoogle ScholarPubMed
Lee, PC, Kini, AS, Ahsan, C, Fisher, E, Sharma, SK. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44(3):541546.10.1016/j.jacc.2004.04.047CrossRefGoogle Scholar
Sico, JJ, Concato, J, Wells, CK, et al. Anemia is associated with poor outcomes in patients with less severe ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(3):271278.10.1016/j.jstrokecerebrovasdis.2011.09.003CrossRefGoogle ScholarPubMed
Tsai, CF, Yip, PK, Chen, CC, Yeh, SJ, Chung, ST, Jeng, JS. Cerebral infarction in acute anemia. J Neurol. 2010;257(12):20442051.CrossRefGoogle ScholarPubMed
Marik, PE. The risks of blood transfusion in patients with subarachnoid hemorrhage. Neurocrit Care. 2012;16(2):343345. author reply 6–9.10.1007/s12028-011-9654-0CrossRefGoogle ScholarPubMed
Whitson, BA, Huddleston, SJ, Savik, K, Shumway, SJ. Risk of adverse outcomes associated with blood transfusion after cardiac surgery depends on the amount of transfusion. J Surg Res. 2010;158(1):2027.10.1016/j.jss.2008.10.015CrossRefGoogle ScholarPubMed
Iancu, A, Buleu, F, Chita, DS, Tutelca, A, Tudor, R, Brad, S. Early hemorrhagic transformation after reperfusion therapy in patients with acute ischemic stroke: analysis of risk factors and predictors. Brain Sci. 2023;13(5):840.10.3390/brainsci13050840CrossRefGoogle ScholarPubMed
Wang, C, Wang, L, Zhong, D, et al. Association between red blood cell distribution width and hemorrhagic transformation in acute ischemic stroke patients. Cerebrovasc Dis. 2019;48(3–6):193199.10.1159/000504742CrossRefGoogle ScholarPubMed
Baracchini, C, Farina, F, Palmieri, A, et al. Early hemodynamic predictors of good outcome and reperfusion injury after endovascular treatment. Neurology. 2019;92(24):e2774e2783.10.1212/WNL.0000000000007646CrossRefGoogle ScholarPubMed
Katsanos, AH, Srivastava, A, Sahlas, DJ, et al. Transcranial Doppler ultrasound to evaluate the risk of hyperperfusion after endovascular stroke thrombectomy. J Neuroimaging. 2024;34(1):5054.10.1111/jon.13168CrossRefGoogle ScholarPubMed
Supplementary material: File

Najdawi et al. supplementary material

Najdawi et al. supplementary material
Download Najdawi et al. supplementary material(File)
File 18.7 KB